Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04830202
Title Expanded Access to Telisotuzumab Vedotin
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors AbbVie

lung non-small cell carcinoma


Telisotuzumab vedotin

Age Groups: senior | adult
Covered Countries

No variant requirements are available.